Try Alerts Free   |   Login
Consumer Staples › Pharmaceutical Preparations

MDVL Price Correlated With Financials For MedAvail Holdings

Free historical financial statements for MedAvail Holdings. See how revenue, income, cash flow, and balance sheet financials have changed over 41 quarters since 2012. Compare with MDVL stock chart to see long term trends.

MDVL Stock Compared to Quarterly

MDVL Income Statement

Revenue, Net:9114000
Revenue Per Share:0.1292
Cost of Goods & Services Sold:8613000
Gross Profit:501000
Selling, General & Admin Expense:6535000
Research & Development Expense:493000
Total Operating Expenses:13270000
Operating Income:-13022000
Income Taxes:0
Net Income:-13022000
Earnings Per Share, Basic:-0.4
Shares Outstanding, Basic Avg:70555977

MDVL Cash Flow

Operating Activities Net Income:
Change in Accounts Receiveable:589000
Net Cash from Operations:-13264000
Net Cash from Operations Per Share:-0.188
Net Cash from Financing Activities:-23000
Property, Plant & Equipment Purchases:343000
Net Cash from Investing Activities:-852000
Net Change in Cash & Equivalents:-14139000

MDVL Balance Sheet

Cash and Cash Equivalents:5950000
Accounts Receivable, Net:1748000
Inventories:5088000
Total Current Assets:15891000
Property, Plant & Equipment, Net:6175000
Total Assets:27692000
Total Short-Term Liabilities:9367000
Long Term Debt, Non-Current Portion:9608000
Total Liabilities:21077000

Insider Trading

 
Change
Value
Transaction
SEC Form 4
ABG WTT-MedAvail Ltd   10% Owner
14,117,646 sh at $1
$14,999,999
Buy

Data imported from MedAvail Holdings SEC filings. Check original filings before making any investment decision.